cyclohexanol has been researched along with Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, L; Salgado, A; Salgado, JV; Sierra-Siegert, M | 1 |
| Davis, E; Egerdie, B; Evans, R; Mackenzie, L; Nickel, JC; Shrewsbury, SB | 1 |
| Chan, JH; Chen, CH; Robson, D; Tan, HK | 1 |
| Capua, AD; Castrogiovanni, A; Ciani, V; Lazzeri, L; Luisi, S; Pacchierotti, C; Pasquini, R; Petraglia, F | 1 |
| Lurie, SD; Makari-Judson, G; Reuben, SS | 1 |
| Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM | 1 |
| Arnecke, B; Guidry, JR; Heisler, MA | 1 |
| Gitlin, MJ | 1 |
| Hodgman, MJ; Krenzelok, EP; Martin, TG | 1 |
| Kolecki, P | 1 |
| Adès, J; Lejoyeux, M | 1 |
| Haddad, P | 1 |
| Mekler, G; Woggon, B | 1 |
| Machado, JF; Roxanas, MG | 1 |
2 review(s) available for cyclohexanol and Syndrome
| Article | Year |
|---|---|
Antidepressant discontinuation: a review of the literature.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
3 trial(s) available for cyclohexanol and Syndrome
| Article | Year |
|---|---|
A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclohexanols; Cystitis, Interstitial; Cystoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Urinary Bladder; Young Adult | 2016 |
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Climacteric; Cyclohexanols; Drug Repositioning; Female; Humans; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome.
Topics: Analgesics; Cyclohexanols; Female; Humans; Mastectomy; Middle Aged; Pain Measurement; Pain, Postoperative; Perioperative Care; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
9 other study(ies) available for cyclohexanol and Syndrome
| Article | Year |
|---|---|
Depersonalization and derealization syndrome: report on a case study and pharmacological management.
Topics: Adult; Cyclohexanols; Depersonalization; Female; Humans; Lamotrigine; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Triazines; Venlafaxine Hydrochloride | 2012 |
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Syndrome; Venlafaxine Hydrochloride | 2009 |
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders | 2007 |
Serotonin syndrome induced by administration of venlafaxine and phenelzine.
Topics: Antidepressive Agents; Central Nervous System Diseases; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Syndrome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy.
Topics: Antidepressive Agents, Second-Generation; Coma; Cyclohexanols; Drug Interactions; Female; Fever; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Tranylcypromine; Venlafaxine Hydrochloride | 1997 |
Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks.
Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
A case of serotonin syndrome caused by venlafaxine and lithium.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanols; Drug Interactions; Female; Humans; Lithium Compounds; Middle Aged; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride | 1997 |
Serotonin syndrome in combined moclobemide and venlafaxine ingestion.
Topics: Adult; Benzamides; Central Nervous System Depressants; Cyclohexanols; Drug Interactions; Drug Overdose; Ethanol; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride | 1998 |